The bioavailability of
rosuvastatin is reduced by
antacids but the
clinical significance of this is uncertain.
No interaction occurs with
rosuvastatin when the doses are separated by 2 hours. The manufacturers of
rosuvastatin recommend that it is not given within 2 to 3 hours of
antacids.